Omega-3, HDL cholesterol and the APOA1 gene

Fish oil is one of the most widely recommended supplements for heart health. But a single gene variant can turn its best-known benefit upside down.

HDL is the cholesterol you want high

HDL is the “good” cholesterol that helps clear excess cholesterol from your arteries. Most heart-healthy advice aims to keep it up, and omega-3 fatty acids are usually part of that plan.

For some, omega-3 lowers HDL

The APOA1 gene builds the main protein in HDL particles. The common variant rs670 flips the usual response: in carriers, omega-3 supplementation tends to lower HDL rather than raise it. The very supplement meant to help can quietly work against them.

What carriers should do instead

For rs670 carriers, the smarter route to better cholesterol is often phytosterols, plant compounds that lower LDL (the “bad” cholesterol) without the adverse HDL effect. This is exactly the kind of swap a genetic result makes obvious and a generic recommendation misses.

What actually helps

Carriers benefit from substituting phytosterols for omega-3 as a cholesterol strategy, while non-carriers can keep using omega-3 in the usual way. Either way, the point is to match the supplement to the gene rather than to the headline.

The science, in depth

APOA1 rs670 is a promoter-region variant affecting apolipoprotein A-I expression and the HDL response to polyunsaturated fat. In carriers, the expected omega-3-driven HDL increase is attenuated or reversed, which underpins the APOA1-specific recommendation to favour phytosterols for cholesterol management.